Biophytis to Participate in Four Key Events in Q4 2025 Biophytis announces its participation in four major international events that reflect the complementarity of its development strategy: CF&B Midcap Events Paris, September 30 – October 1, 2025 Geneva, December 10, 2025 BIO-Europe (Vienna, November 3–5, 2025) SCWD Annual Conference (Rome, December 11–13, 2025) In Paris…
Biophytis at the Forefront of Longevity Innovation at the World Aging & Rejuvenation Conference 2025 Biophytis announces its participation in the 7th edition of the World Aging & Rejuvenation Conference (ARC 2025), to be held in Vienna, Austria, from July 9 to 10, 2025. As part of this internationally renowned event dedicated to aging and…
Biophytis Powers Innovation in Obesity, Muscle Health, and Longevity at BIO International 2025 Biophytis is proud to announce its successful participation at the BIO International Convention 2025, the world’s largest and most comprehensive biotechnology event. Hosted at the Boston Convention & Exhibition Center from June 16-19, 2025, the convention gathered 20,000 industry leaders from across…
Biophytis announces its participation in the BIO International Convention from June 16 to 19 Biophytis announces its participation to the BIO International Convention, which will take place this year in Boston, USA, from June 16 to 19, 2025. Edouard Bieth, Chief Strategy Officer at Biophytis, will be present and will take part in numerous meetings…
Biophytis Highlights Innovative Approach to Obesity Treatment During Key ECO 2025 Presentation Biophytis announced its active participation at the 32nd European Congress on Obesity (ECO 2025), held from May 11 to 14 in Malaga, Spain. During this premier international event, which brings together leading experts, clinicians, researchers, and industry stakeholders to discuss the latest advances…
Biophytis announces its participation to the BIO-Europe Spring 2025 in Milan Biophytis is pleased to announce its participation in BIO-Europe Spring 2025, taking place in Milan, Italy, from march 17 to 19, 2025. Edouard Bieth, our Chief Business Officer, will take part in numerous meetings throughout the conference. As one of the most innovative biotechnology…
Biophytis announces its participation in the 15th International Conference on Frailty and Sarcopenia Research (ICFSR) Biophytis announces its participation in the International Conference on Frailty and Sarcopenia Research & Geroscience Task Force (ICFSR), taking place from March 12 to 14 in Toulouse. The International Conference on Frailty and Sarcopenia Research (ICFSR) is a leading annual…
Biophytis announces its participation to the BIOMED FORUM investor conference Biophytis announces its participation in the Biomed Forum organized by All Invest Securities on February 4, 2025, in Paris. The Biomed Forum is the annual event dedicated to the healthcare sector, fostering connections between biotech or medtech companies and institutional investors. This will be an…
Biophytis Will Be In San Franscico During The 2025 JP Morgan Healthcare Conference Will participate also in the following events: Sachs Conference – BioPharma Obesity Innovation Forum The BIO@JPM Week Conference Biophytis announces its participation in the inaugural BioPharma Obesity Innovation Forum (#Sachs_BOIF) on January 11, 2025, in San Francisco, as well as in the…
Biophytis its participation in the 17th edition of the SCWD Congress (Society on Sarcopenia, Cachexia & Wasting Disorders), taking place from December 6 to 8, 2024, in Washington, D.C. As part of the congress, Biophytis will host an Obesity Investor Call on the topic: “GLP-1 RA weight loss therapy-induced muscle loss: A medical need to…
Biophytis announces its participation in several events in Europe and the United States over the coming months Biophytis outcomes for patients suffering from age-related diseases, has announced its participation in several conferences until the end of the first half of 2024. Annual scientific conference on sarcopenia Biophytis management will take part in the 14th International…
Biophytis announces its participation in several conferences in Europe and the US during the first quarter of 2024 Biophytis management will be in San Francisco for meetings with potential partners and investors at the 42nd JP Morgan Healthcare Conference, to be held from 8 to 11 January 2024. In addition, the company will be present:…
Biophytis to attend BIO-Europe in Munich Biophytis announces that the company is attending the BIO-Europe conference which will be held in Munich, Germany, November 6th to 8th 2023. The conference will, as every year, bring together all the players in the pharmaceutical and biotech industries. As part of the international development strategy for Sarconeos (BIO101)…
Next week, our CBO, Edouard Bieth, will be attending the Pharma Partnering Summit in Boston, US! Hope to meet you there to learn more about how Biophytis is contributing to the future of biotechnology and discuss potential partnership opportunities. To arrange a one-to-one meeting, please send a message directly to the following email address: edouard.bieth@biophytis.com…
During the 25th annual H.C. Wainwright Global Investment Conference, Biophytis’ CEO Stanislas Veillet presented the company, its ambitions and the latest progress it made on its various projets. A replay will be available for 90 days at the following link: https://journey.ct.events/view/1037e68b-3f79-4b25-9a15-27affba4d7c4 Watch here
Biophytis to Participate at the H.C. Wainwright 25th Global Investment Conference in New York Biophytis announces that its CEO, Stanislas Veillet, will participate and hold a presentation at the “H.C. Wainwright 25th Annual Global Investment Conference”, which takes place from September 11 to 13, 2023 in New York. The presentation will be available post-meeting on…
Biophytis to participate at the BIO International Convention in Boston from the 5th to the 8th of June Biophytis announces it will participate at the Biotechnology Innovation Organization (BIO) International Convention to be held in Boston from the 5th to the 8th of June 2023, alongside thousands of world leaders in biotechnology and the pharmaceutical…
Biophytis announces its participation in two major investor conferences in January, in the United States and in France: the JP Morgan Healthcare Conference and the Invest Securities Biomed Event.
Biophytis participates in H.C. Wainwright 24th Annual Global Investment Conference Biophytis made a presentation to investors on the 12th of September in New York, on the occasion of the 24th Global Investment Conference organised by the HC Wainwright bank, which is being held from 12 to 14 September 2022 in New York. During this oral…
Biophytis to update on the development of Sarconeos (BIO101) in Covid-19 at the 4th Annual Longevity Therapeutics Summit Phase 2-3 COVA study results expected in Q3 2022 Biophytis announces its CEO, Stanislas Veillet, PhD, has been hosting a presentation at the 4th Annual Longevity Therapeutics Summit in San Francisco. The Biophytis presentation entitled “Discussing the…
Biophytis presents the development of Sarconeos (BIO101) in Phase 3 for the treatment of Sarcopenia at the 15th SCWD International Congress Biophytis announced that it is giving an oral presentation on the development of Sarconeos (BIO101) for the treatment of sarcopenia at the 15th International SCWD Congress (Society on Sarcopenia, Cachexia & Wasting disorders). This…
Biophytis announces its participation at the BIO International Convention in San Diego from the 13th to the 16th of June Biophytis announces it will participate, represented by its CEO Stanislas Veillet and its Business Development Director Benoit Canolle, at the Biotechnology Innovation Organization (BIO) International Convention to be held in San Diego from the 13th…
Biophytis announces its participation to a Virtual Workshop the development of Function promoting therapies for the elderly, organized by the National Institute on Aging based in Baltimore, USA. Dr Waly Dioh, Chief Clinical Operations Officer of Biophytis, will present the progress of its drug candidate and will meet with public and private players as well…
Biophytis announces its management will participate and meet with investors at the following upcoming events and conferences: H. C. Wainwright 23rd Annual Global Investment ConferenceSeptember 13 to 15 – Virtual Amsterdam MidCap EventSeptember 20 to 21 – Virtual Investor Access EventSeptember 27 to 28 – Paris HealthTech Innovation DaysOctober 4 to 5 – Paris European…
SAVE THE DATE THURSAY, SEPTEMBER 30 • ROUNDTABLE 9:00-9:30 AM USA (EST) TIME SARA results will be presented and discussed, in a dedicated session, during the next ICFSR congress SARCONEOS BIO101 IN SARCOPENIA: LESSONS LEARNED FROM THE SARA PROGRAM Biophytis experts : Cendrine Tourette, PhD – Waly Dioh, PhD – Jean Mariani, with the presence…
Biophytis to Participate in Upcoming Investor & Partnering Conferences During J.P. Morgan Week 2021
Biophytis is participating to: – The Geneva European Midcap digital event, December 1rst & 2 2020 – The “Anticovid” Biotech sector conference organized by the SFAF on Wednesday, December 9 – The 13th International SCWD virtual conference, December 11-13 2020
Biophitys will participate in the following events: Mid-Cap Event :October 19 & 20th Galien Week of Innovation: Oct 26-30
Biophytis recently attended the Digital ChinaBio conference taking place August 25-27, and will also attend the following conferences: The HC Wainwright 22nd Annual Global Investment Conference – September 14-16, 2020 (Virtual Conference) The HTID (Health Tech Innovation Days): October 5th & 6th, Paris Bio Europe Fall : October 26-29th (Virtual Conference)
